OpenEvidence hits $15 billion valuation, says nearly two-thirds of U.S. doctors use its AI search tool

OpenEvidence hits $15 billion valuation, says nearly two-thirds of U.S. doctors use its AI search tool

N
News Editor
2026-10-21 15:23:46
Miami-based AI startup OpenEvidence has reached a $15 billion valuation, according to the information cited by Techub News. The company said nearly two-thirds of physicians in the United States are using its AI-powered search engine to support clinical decision-making. OpenEvidence said that about 1 million U.S. doctors made more than 42 million queries on the platform last month. Physicians use its chatbot to search medical journals and clinical guidelines, with the tool aimed at helping diagnosis and treatment decisions. The company’s growth has largely come through word of mouth. Founder Daniel Nadler said OpenEvidence is the first consumer internet application in healthcare to achieve viral adoption. The report was attributed to Ars Technica.

Miami-based AI startup OpenEvidence has reached a $15 billion valuation, according to Techub News.

The company said nearly two-thirds of doctors in the United States are using its AI-powered search engine to assist with clinical decision-making. Last month, about 1 million U.S. physicians made more than 42 million queries on the platform.

Doctors use the company’s chatbot to search medical journals and clinical guidelines to help diagnose and treat patients.

OpenEvidence said its growth has been driven mainly by word of mouth. Founder Daniel Nadler said it is the first consumer internet application in healthcare to achieve viral adoption.

The report was attributed to Ars Technica.

This article was originally published by Bit.Fan. For more cryptocurrency news and market insights, visit www.bit.fan.
100

Disclaimer:

The market information, project data, and third-party content displayed on this platform are for industry information sharing only and do not constitute any form of investment advice or return commitment.

Cryptocurrency trading carries high risks. Users should fully assess their risk tolerance and make independent decisions. All profits, losses, and legal responsibilities are borne by the users themselves.